comparemela.com

Latest Breaking News On - ரோட்ஜர் றீனேய் - Page 1 : comparemela.com

Scottrade Founder Riney Gives $1 8M to UAMS Myeloma Center

The Myeloma Institute, located within the Winthrop P. Rockefeller Cancer Institute at UAMS (UAMS) The Paula and Rodger Riney Foundation have given $1.8 million to the University of Arkansas for Medical Sciences Myeloma Center in the Winthrop P. Rockefeller Cancer Institute to fund multiple myeloma research. Rodger Riney is the founder and former CEO of the discount brokerage firm Scottrade of St. Louis. He was diagnosed with multiple myeloma in 2015 and has since become an advocate for research and treatment of the disease, including serving on the board of directors for the Multiple Myeloma Research Foundation, UAMS said in a news release. 

Forest Park in St Louis to open new $5 million Anne O C Albrecht nature playscape in June

Forest Park in St Louis to open new $5 million Anne O C Albrecht nature playscape in June
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

St Louis biotech startup Arch Oncology raises $105M in Series C funding

St Louis biotech startup Arch Oncology raises $105M in Series C funding
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

$10 million gift supports new myeloma research center at Ohio State

 E-Mail COLUMBUS, Ohio The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has received a $10 million gift from the Paula and Rodger Riney Foundation to establish the Riney Family Foundation Myeloma Center for Advanced Research Excellence (Myeloma CARE). A collaborative effort of the OSUCCC - James Drug Development Institute (DDI) and the Division of Hematology at Ohio State, this new center is focused on accelerating myeloma drug discovery and development projects at the OSUCCC - James. Initial projects will include the creation of a comprehensive, multi-institutional database for categorizing patient samples and correlating de-identified health data for future scientific studies aimed at better understanding and treatment of multiple myeloma.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.